Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Bacterial lipopolysaccharide (LPS) disrupts endothelial barrier function.
• Lipid A is the key component of LPS responsible for this disruption.
• Gram-negative sepsis involves vascular endothelial dysfunction due to LPS.

Purpose of the Study:

• To investigate the efficacy of endotoxin-neutralizing protein (ENP) in preventing LPS-induced endothelial barrier dysfunction.
• To determine if ENP can block LPS-mediated changes in endothelial cell signaling and structure.
• To assess ENP's therapeutic potential for gram-negative sepsis.

Main Methods:

• Exposure of bovine pulmonary artery endothelial cells to LPS and ENP.
• Measurement of macromolecule flux (14C-albumin) across cell monolayers.
• Analysis of protein tyrosine phosphorylation and actin organization.

Main Results:

• LPS increased transendothelial albumin flux and induced tyrosine phosphorylation of paxillin and actin depolymerization.
• Coadministration of ENP with LPS dose-dependently inhibited these LPS-induced effects.
• ENP provided cross-protection against LPS from various gram-negative bacteria.

Conclusions:

• Lipid A is the bioactive component of LPS mediating endothelial barrier dysfunction.
• Endotoxin-neutralizing protein effectively blocks LPS-induced endothelial cell responses.
• ENP represents a promising therapeutic strategy for endotoxemia and gram-negative sepsis.